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Abstract 
There are 12 putative toxin-antitoxin (TA) loci in the Thermus thermophilus 
HB27 genome, including four VapBC and three HicBA families. Expression of these 
seven putative toxin genes in Escherichia coli demonstrated that one putative VapC 
toxin TTC0125 and two putative HicA toxins, TTC1395 and TTC1705, inhibited cell 
growth, and co-expression with cognate antiotoxin genes rescued growth, indicating 
that these genes function as TA loci. In vitro analysis with the purified TTC0125 and 
total RNA/mRNA from E. coli and T. thermophilus showed that TTC0125 has RNase 
activity to rRNA and mRNA; this activity was inhibited by the addition of the purified 
TTC0126. Translation inhibition assays showed that TTC0125 inhibited protein 
synthesis by degrading mRNA but not by inactivating ribosomes. Amino acid 
substitutions of 14 predicted catalytic and conserved residues in VapC toxins to Ala or 
Asp in TTC0125 indicated that nine residues are important for its in vivo toxin activity 
and in vitro RNase activity. These data demonstrate that TTC0125-TTC0126 functions 
as a VapBC TA module and causes growth inhibition by degrading free RNA. This is the 
first study to identify the function of TA systems in T. thermophilus. 
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Introduction 
The gram-negative bacterium Thermus thermophilus, which was isolated from 
a hot spring in Japan (Henne et al. 2004; Oshima and Imahori 1974), is an extremely 
thermophilic model organism, which can grow in temperatures up to 85 ºC. T. 
thermophilus belongs to the phylum Deinococcus-Thermus, a small group of bacteria 
that are highly resistant to environmental hazards (Griffiths and Gupta 2007). The genus 
Thermus is closely related to Archaea and the genus Mycobacterium in the phylogenetic 
tree (Omelchenko et al. 2005).  
Toxin-antitoxin (TA) loci are widely distributed in chromosomes and plasmids of 
Bacteria and Archaea (Grønlund and Gerdes 1999; Makarova et al. 2009; Pandey and 
Gerdes 2005; Gerdes et al. 2005; Krupovic et al. 2013). The chromosomes of some of 
these bacteria contain several TA loci, especially in one of the Mycobacterium species, 
M. tuberculosis, which possesses the largest number of putative TA loci on its 
chromosome, accounting for 79 loci (Ramage et al. 2009). TA systems consist of two 
small genes that encode a low molecular weight toxic protein (toxin) which reacts with 
intracellular target molecules related to essential cellular processes, such as DNA 
replication, protein translation, membrane integrity, and cell wall synthesis (Bertram 
and Schuster 2014; Maisonneuve et al. 2013; Page and Peti 2016), and a cognate 
antitoxin protein or RNA that inhibits toxin activity. Initially, TA loci were reported to 
play a role in bacterial programmed cell death for maintaining plasmid stability by 
killing the daughter cells that failed to inherit the plasmids (Winther and Gerdes 2011), 
or for acting as antiviral factors (Hazan and Engelberg-Kulka 2004; Pecota and Wood, 
1996). More recently, it was recognized that the toxins play roles in response to cellular 
stresses (Bertram and Schuster 2014), such as amino acid starvation and the presence of 
antibiotics (Fauvart et al. 2011; Gerdes et al. 2005; Maisonneuve and Gerdes 2014), and 
triggering bacterial persistence (Yamaguchi and Inouye 2011). The vast majority of TA 
systems in chromosomes of Bacteria and Archaea are not redundant, likely due to each 
system developing different responses to specific stresses (Wang and Wood 2011). 
Currently, TA systems are grouped into six classes according to the mechanisms used by 
the antitoxins to neutralize the activities of the toxins.  
The type II TA system is composed of a stable toxin protein and an unstable 
antitoxin protein. Under normal growth conditions, the antitoxin neutralizes toxin 
activity by forming a stable protein complex. When an environmental stressor is present, 
the antitoxin protein is degraded via proteolysis such that the toxin is released from the 
protein complex and becomes active to target intracellular molecules, such as mRNA at 
the ribosomal A site (Christensen and Gerdes 2003), initiator tRNAfMet (Winther and 
Gerdes 2011), Sarcin-Ricin loop of 23S rRNA (Winther et al. 2013), and glutamyl-
tRNA synthetase (Germain et al. 2013), to inhibit cell growth or cause cell death. Most 
type II toxins function as RNases for degrading mRNA, either in a ribosome-dependent 
or independent manner (Unterholzner et al. 2014), such as MazF, Kid, ChpBK, MqsR, 
VapC, and HicA.  
VapBC of the type II TA system is the most widely expanded TA family and its 
toxin, VapC, contains a PIN domain, which functions as a nuclease enzyme and cleaves 
single stranded RNA (Arcus et al. 2011). VapBC is often found in prokaryotic 
organisms, such as M. tuberculosis, one of the most devastating pathogenic bacteria, 
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which contains 45 VapBC loci (Arcus et al. 2011); however, most have not been well 
characterized until recently. The PIN domain consists of three highly conserved 
negatively-charged amino acids and is predicted to have RNase activity (Arcus et al. 
2011). VapC toxins from different organisms were reported to have different target 
specificities; for example, VapC20 of M. tuberculosis inhibits translation by cleavage of 
23S ribosomal RNA (Winther et al. 2013), and both VapC of Shigella flexneri and 
VapCLT2 of Salmonella enterica site-specifically cleave initiator tRNA (Winther and 
Gerdes 2011); on the other hand, VapC-mt4 of M. tuberculosis degrades mRNA (Sharp 
et al. 2012).  
Little is known about HicAB, a novel Type II TA system family that was 
identified by Makarova et al. (2006). The Escherichia coli HicA toxin inhibits cell 
growth by mRNA degradation (Jørgensen et al. 2009), and the HicA from Burkholderia 
pseudomallei and Pseudomonas aeruginosa induces growth arrest and persistence in the 
presence of ciprofloxacin or ceftazidime (Butt et al. 2014; Li et al. 2016). 
Despite many studies on mesophilic bacteria, including pathogens, the 
mechanisms and roles of TA systems in thermophilic microorganisms remain unknown. 
Based on the toxin-antitoxin database (Shao et al. 2011), 12 TA loci are predicted to be 
present in the T. thermophilus HB27 genome, of which seven are classified into known 
TA families, three (TTC1395-TTC1394, TTC1549-TTC1548, and TTC1705-TTC1704) 
in HicAB and four (TTC0113-TTC0114, TTC0125-TTC0126, TTC1207-TTC1208, and 
TTC1804-TTC1805) in VapBC; however, experimental analyses on these TA loci have 
not yet been reported. Here, we document the results of genetic analyses of these seven 
loci, and present detailed biochemical analyses of TTC0125-TTC0126. 
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Materials and methods 
 
Bacterial strains, plasmids and media 
 T. thermophilus HB27 was used for genome isolation and purification of total 
RNA. E. coli strains DH5αZ1 (DH5α harboring attB:: PlacIq-lacI, PN25-tetR, Spr; Lutz 
and Bujard 1997) and Rosetta (DE3) were used for plasmid construction and expression 
of toxin/TA genes from pZE21MCS2 (ColE1ori, PLtetO-1, Knr; Lutz and Bujard 1997) 
and for production of TTC0125/TTC0126 proteins with pET28a, respectively. DH5αZ1 
and pZE21MCS2 were purchased from Expressys. T. thermophilus and E. coli strains 
were cultured in TM medium (Koyama et al. 1986) at 70 °C and in LB medium at 37 °C, 
respectively.  
 
Plasmid construction 
To construct plasmids expressing the toxin genes or the TA modules under the 
control of a strictly regulated promoter, PLtetO-1, each toxin gene or the TA locus was 
PCR-amplified with the primers listed in Table S1 from the T. thermophilus HB27 
genome. Then, fragments were digested with KpnI and SalI, which were added just 
upstream of the initiation codon and downstream of the termination codon, respectively, 
and cloned into the respective sites of pZE21MCS2, using strain DH5αZ1 as a host. 
 For production and purification of the TTC0125 toxin and TTC0126 antitoxin, 
the TA locus and TTC0126 were PCR-amplified with primers TTC0126 F NdeI and 
TTC0125 R XhoI, and TTC0126 F NdeI and TTC0126 R XhoI, respectively. The 
resultant fragments were cloned into the respective sites of pET28a, giving rise to 
pET28-TTC0125-TTC0126 and pET28-TTC0126, respectively. In both plasmids, 
TTC0126 was fused in-frame with the 6xHis-tag in the vector at the N-terminus, and the 
XhoI site was located just downstream of the termination codon of TTC0125 of pET28-
TTC0125-TTC0126 and TTC0126 of pET28-TTC0126. 
 The TT_P0042 gene encoding a β-glycosidase was PCR-amplified and cloned 
into pET28a, giving rise to pET28-TTP0042. This plasmid was used for in vitro 
transcription and translation assays. The tetR gene from E. coli was also cloned into 
pET28a to construct pET28-tetR, and used for in vitro transcription and RNase assays. 
 All plasmid constructs were confirmed by nucleotide sequencing with a 
CEQ8000XL DNA sequencer (Beckman-Coulter). 
 
Growth inhibition assay 
The strain DH5αZ1 harboring the pZE21MCS2 plasmid containing each toxin 
gene or TA locus was cultured in liquid LB medium with 50 μg/mL of kanamycin at 43 
ºC. When the O.D.600 of the culture reached approximately 0.2, 100 ng/mL doxycycline 
(Dox) was added to induce gene expression. Cell growth was monitored periodically by 
measuring O.D.600. Three independent experiments were performed. 
 
Purification of TTC0125 and TTC0126 
The TTC0125 toxin was purified according to Winther and Gerdes (2011). E. 
coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 was cultured in LB medium 
supplemented with 50 μg/mL kanamycin and 20 μg/mL chloramphenicol at 30 °C. 
When O.D.600 reached 0.5, 0.2 mM IPTG was added, and, after further culturing for 5 h, 
cells were collected by centrifugation at 5000 x g for 10 min at 4 °C. Then, the cells 
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were re-suspended in ice-cold Lysis buffer (50 mM NaH2PO4, 100 mM NaCl, 20 mM 
imidazole, 0.5 mM PMSF (SIGMA), pH 7.4), and disrupted by sonication. After the cell 
debris were removed by centrifugation at 10,000 x g for 20 min at 4 ºC, a Ni-NTA 
agarose resin (Qiagen) was added to the supernatant and incubated for 2 h at 4 ºC, and 
subsequently loaded onto a gravity column. The column was washed extensively with 
Wash buffer (50 mM NaH2PO4, 100 mM NaCl, 20 mM imidazole, pH 7.4), and the 
protein complex of TTC0125-TTC0126 was eluted with Elution buffer (50 mM 
NaH2PO4, 100 mM NaCl, 200 mM imidazole, pH 7.4). Next, the protein complex was 
denatured by dialyzing the complex overnight at 4 ºC with Denaturation buffer (100 
mM NaH2PO4, 10 mM Tris–HCl, 9.8 M Urea, pH 7.4), and the solution was again 
loaded onto a Ni-NTA agarose column. The denatured TTC0125 was eluted in the flow-
through fraction, and refolded by the subsequent four-step dialysis against: (i) 1☓ PBS, 
0.1 % Triton X-100, 5 mM DTT, (ii) 1☓ PBS, 5 mM DTT, (iii) 1☓ PBS, 5 mM DTT, and 
(iv) 1☓  PBS, 20 % glycerol, 1 mM DTT for 4 h in each dialysis.  
 For purification of TTC0126, E. coli Rosetta (DE3) harboring pET28-
TTC0126 was cultured and the cell-free extract was prepared as previously described. 
TTC0126 was purified from the extract directly with a Ni-NTA agarose. The 
purification steps were monitored by SDS-PAGE according to Laemmli (1970).  
 
RNA degradation assay 
 100 pmol of the purified TTC0125 protein, dialyzed against Reaction buffer 
(50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7.4) prior to the 
reaction, was incubated with 1 μg of total RNA from E. coli and T. thermophilus, which 
was prepared using a RNeasy Mini Kit (Qiagen), or an in vitro-transcribed tetR mRNA, 
which was prepared using pET28-tetR and an in vitro Transcription T7 Kit (TAKARA) 
and purified with RNeasy Mini Kit (Qiagen) kit, at 50 ºC in Reaction buffer. After 5, 15, 
30, or 60 min of incubation, the reaction was stopped by adding 1x loading buffer 
(47.5 % formamide, 0.01 % SDS, 0.01 % bromophenol blue, 0.5 mg/ml EtBr, 0.5 mM 
EDTA) and placed on ice immediately. Then, the samples were loaded onto a denaturing 
agarose gel (1% agarose, 6.5% formaldehyde, 0.4 M MOPS, 100 mM sodium acetate, 
10 mM EDTA) and analyzed. To test the inhibitory effect of TTC0126, 100 pmol of 
TTC0125 was incubated with 500 pmol of the purified TTC0126, which was also 
dialyzed against Reaction buffer, at 50 ºC for 15 min prior to the reaction, and used for 
the assay. 
 For measuring activity against intact ribosomes, ribosomes were purified from 
E. coli and T. thermophilus cells according to Pongs et al. (1973) and Trauner et al. 
(2011). Then, 10 μg of TTC0125 was incubated with 50 μg of ribosomes in Reaction 
buffer at 50 ºC for 60 min, and rRNA was purified with an RNeasy Mini Kit for gel 
electrophoresis. 
 For measuring activity against tRNA, the small RNA fraction containing 
tRNA was prepared from E. coli using ISOGEN II (NIPPON GENE). Then, 1 μg of the 
sample was incubated with TTC0125 as previously described, and resolved by an 8 % 
denaturing PAGE. After the sample was electroblotted onto a Hybond-N membrane, the 
initiator tRNA was hybridized with a biotin-labelled DNA probe, tRNAMet. Detection 
was conducted using a Chemiluminescent Nucleic Acid Detection Module (Thermo) 
and an LAS-2000 detector (Fuji film). 
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In vitro translation inhibition assay 
An in vitro translation inhibition assay was performed under the following 
conditions, using the in vitro transcribed TT_P0042 mRNA, which was synthesized 
with pET28-TTP0042 as a template and the in vitro Transcription T7 Kit, and a 
PUREfrex 2.0 kit (GeneFrontier; Shimizu et al. 2001). For each condition, the amount 
of the purified TTC0125, TTC0126 proteins, and the template mRNA used were 45, 270 
pmol, and 2.5 µg, and the substrate-tRNA mixture (Solution I, PUREfrex), the enzyme 
mixture (Solution II), and the ribosome (Solution III) solutions used were 10, 1, and  
2 µL in a total volume of 20 µL, respectively. 
 
Condition 1. The template mRNA was incubated with TTC0125 at 37 ºC for 30 min. 
prior to in vitro translation. 
Condition 2. The template mRNA was incubated with TTC0125 as previously described, 
then TTC0126 was added and the solution was further incubated for 15 min. After that, 
the translation reaction was started. 
Condition 3. TTC0125 and TTC0126 were mixed and incubated at 37 ºC for 15 min. 
then the template mRNA was added and incubated further for 30 min. After that, the 
translation reaction was started. 
Condition 4. The ribosome (Solution III) was incubated with TTC0125 at 37 ºC for 30 
min. Then, the translation reaction was started by adding the template mRNA, Solution 
I and II. 
Condition 5. The ribosome was incubated with TTC0125 as previously described, then 
TTC0126 was added and the solution was further incubated for 15 min. After that, the 
translation reaction was started. 
Condition 6. TTC0125 and TTC0126 were mixed and incubated at 37 ºC for 15 min, 
then the ribosome was added and incubated further for 30 min. After that, the translation 
reaction was started. 
 
 The in vitro translation reaction was performed at 37 ºC for 4 h, and the 
translated TT_P0042 protein, containing the 6xHis-tag at its N-terminus, was detected 
by Western blotting using an anti-His antibody (Qiagen) and an ECL Prime Western 
Blotting Detection kit (GE Healthcare). Detection was performed using an LAS-2000 
detector (Fuji film). 
 
Site-directed mutagenesis 
 Single amino acid-substitution mutants of TTC0125 were constructed using 
the pZE21MCS2 plasmid harboring TTC0125 and pET28-TTC0125-TTC0126 as 
templates, primers listed in Table S1, and a QuickChange site-directed mutagenesis kit 
(Agilent Technologies). The resultant pZE21MCS2 plasmids harboring the mutant 
TTC0125 were used for the growth inhibition assays, and pET28-TTC0125-TTC0126 
harboring mutant genes were used for protein purification and biochemical assays, as 
previously described. 
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Results and discussion 
 
Identification of functional TA loci through growth inhibition assays 
In the T. thermophilus HB27 genome, seven TA loci were predicted to be 
known TA families in the toxin-antitoxin database (Shao et al. 2011). Similarity 
searches of these putative toxins with the validated toxins in the Uniprot database 
indicated low-to-moderate similarities. TTC0113, TTC0125, TTC1207, and TTC1804, 
classified in the VapC family, showed 24, 44, 12, and 13 % similarity to VapC of 
Mycobacterium smegmatis (VAPC_MYCS2) (McKenzie et al. 2012), and TTC1395, 
TTC1549 and TTC1705 showed 37, 13 and 42 % similarity to HicA of E. coli 
(HICA_ECOLI), respectively (Jørgensen et al. 2009). Likewise, their cognate antitoxins 
also showed similar results. TTC0114, TTC0126, TTC1208, and TTC1805 showed 24, 
37, 18, and 47 % similarity to the VapB antitoxin of M. smegmatis (VAPB_MYCS2), 
and TTC1394, TTC1548, and TTC1704 showed 27, 35 and 27 % similarity to the HicB 
antitoxin of E. coli, respectively (HICB_ECOLI).  
To test whether these seven TA loci are functional, the toxin genes were cloned 
with or without their cognate antitoxin genes into the plasmid pZE21MCS2 and 
expressed under the control of the PLtetO-1 promoter in E. coli. This promoter is strictly 
regulated in the presence of the TetR repressor in strain DH5αZ1, and expression can be 
induced with the addition of Dox (Lutz and Bujard 1997). Strains harboring the 
plasmids were cultured at 43 °C and gene expression was induced when the O.D.600 of 
the culture reached approximately 0.2.  
As shown in Fig. 1a, expression of one VapC (TTC0125) and two HicA 
(TTC1395, TTC1549) genes strictly inhibited cell growth, whereas the other toxin 
genes had almost no effect. The growth-inhibitory effects of the former three toxin 
genes were more evident at 43 °C compared to 37 °C (data not shown), indicating that 
these toxins are more active at higher temperatures. Moreover, the effects were canceled 
out by co-expression of their cognate antitoxin genes (Fig. 1b).  
The method used is restricted by assay temperature, as an E. coli strain is used 
as the host. Therefore, we cannot exclude the possibility that the other four toxins may 
also possess toxin activities at higher temperatures, i.e. the growth temperature of T. 
thermophilus. However, we concluded that at least these three loci function as type II 
TA systems in T. thermophilus, and focused on the TTC0125/TTC016 locus for further 
analysis. As these genes are classified into the VapBC family, we hereinafter renamed 
TTC0125 and TTC0126 as TtVapC and TtVapB, respectively. 
 
Purification of TtVapC and TtVapB 
 We adopted the method described by Winther and Gerdes (2011) for TtVapC 
purification. The TtVapBC protein complex was first purified from the cell extracts of E. 
coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 through affinity 
chromatography against the 6xHis-tag attached to the N-terminus of TtVapB; the 
proteins were denatured with a 9.8 M urea treatment. Then, the sample was loaded to 
the Ni-NTA agarose column and TtVapC was purified in a flow-through fraction. The 
purified TtVapC was renatured by a step-wise dialysis, and TtVapB was directly purified 
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by the affinity chromatography from the cell extract of strain Rosetta (DE3) harboring 
pET28-TTC0126.  
The purified TtVapC and TtVapB showed single bands on SDS-PAGE, the size 
of which were 14.7 and 10.0 kDa, respectively (Fig. 2). 
 
TtVapC degrades free RNA but not tRNA or rRNA in intact ribosomes 
VapC family proteins contain a PIN domain and function as RNases (Arcus et 
al. 2011). In order to assess the molecular function of TtVapC, we first analyzed its 
RNase activity using total RNA isolated from both E. coli and T. thermophilus as 
substrates. As shown in Fig. 3ab, the major bands corresponding to 16S and 23S rRNA 
were gradually shifted to low molecular-weight fractions across incubation time with 
TtVapC, indicating that TtVapC degrades at least 16S and 23S rRNA from both 
organisms. This degradation was completely inhibited when TtVapC was incubated with 
TtVapB prior to the reaction, showing that TtVapB functions as antitoxin.  
Some VapC toxins show strict substrate-specificities towards rRNA and tRNA. 
For example, VapC20 of M. tuberculosis cleaves the Sarcin-Ricin loop of 23S rRNA in 
the intact ribosome (Winther et al. 2013), and VapC (MvpT) of Shigella flexneri cleaves 
the anticodon loop of the initiator tRNA (Winther and Gerdes 2011). To examine 
whether TtVapC has such substrate-specificities, we first evaluated its activity toward 
intact ribosomes from E. coli and T. thermophilus. As shown in Fig. S1ab, TtVapC did 
not cleave or degrade 16S or 23S rRNA from both organisms. In order to assess initiator 
tRNA cleavage, small RNA fraction from E. coli was used as a substrate and the tRNA 
was detected by Northern blot hybridization. TtVapC also did not react with the initiator 
tRNA (Fig. S1c). However, TtVapC degrades in vitro-transcribed mRNA of the E. coli 
gene (tetR) in the same manner as total RNA (Fig. 3c). These results strongly indicate 
that TtVapC does not possess substrate- or sequence-specificity, rather it degrades free 
RNA, such as VapC6 of Sulfolobus solfataricus (Maezato et al. 2011), and those of 
some pathogenic bacteria (Daines et al. 2007; Ramage et al. 2009).  
 
TtVapC inhibits translation by degrading mRNA 
 To gain insights into the in vivo molecular function of TtVapC, an in vitro-
translation assay was conducted using a PUREFrex kit. In this assay, an in vitro-
transcribed TT_P0042 mRNA was used as a template for translation and translated 
6xHis-tagged protein was detected by Western blotting. 
 A control experiment (without TtVapC addition) produced a band of ca. 50.8 
kDa corresponding to the molecular weight of the TT_P0042 protein with a 6×His-tag 
(Fig. 4). When the mRNA was incubated with TtVapC prior to translation, no band was 
observed; also, the band was not observed when TtVapB was added after incubation of 
the mRNA with TtVapC. As the TT_P0042 protein was successfully translated when the 
mRNA was incubated with the TtVapBC complex, it seems likely that TtVapC inhibits 
translation by degrading mRNA. However, pre-treatment of ribosomes with TtVapC 
resulted in a reduction of the translated product; this reduction did not occur when 
TtVapB was added to the ribosome-TtVapC mixture before the translation reaction. 
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Therefore, this result was likely caused by active TtVapC degradation of mRNA during 
translation reaction but not inactivation of ribosomes. Pre-incubation of ribosome with 
TtVapBC did not affect translation efficiency. We therefore conclude that TtVapC 
inhibits translation by degrading mRNA and thereby inhibiting cell growth. 
 
Identification of functionally-important residues in TtVapC   
 We conducted site-directed mutagenesis to identify catalytically-important 
residues of TtVapC. An amino acid sequence alignment of TtVapC with “reviewed” 
VapCs in the Uniprot database (Fig. S2) generated by the T-Coffee program (Notredame 
et al. 2000) indicated that some residues, including the putative catalytic residues in PIN 
proteins, D4, E40, and D99 in TtVapC numbering, are conserved in all VapCs. In 
addition, some residues are conserved in several but not in all VapCs. We selected those 
residues, including the putative catalytic residues, and introduced single amino acid 
substitutions to Ala or Asp. The mutant genes were then introduced into E. coli DH5αZ1 
on pZE21MCS2 and the growth inhibition assays were conducted. 
As shown in Fig. S3, the E23A, T72A, L105D, and V108D mutants showed 
similar growth inhibition as the wild type TtVapC gene, suggesting that these residues 
are not required for its toxin activity. The F71A mutant showed a weaker growth 
inhibition, suggesting that this residue may be required for this activity to some extent. 
In contrast, the D4A, E40A, A76D, G94D, G98D, D99A, S102D, D119A, and D124A 
mutants, including the mutants of the putative catalytic residues, had almost no effect on 
cell growth, demonstrating the importance of these residues for its in vivo toxin activity.  
Since the three-dimensional structure of TtVapC is currently unavailable, we 
developed a three-dimensional model using the Phyre2 program to gain insight into the 
structure-activity relationship of TtVapC (Kelly et al. 2015). The Phyre2 program 
indicated that TtVapC showed a 37 % identity with VapC30 of M. tuberculosis H37Rv 
(PDB No. 4xgr), and a model structure of the second to 128th amino acid of TtVapC 
was constructed based on that of VapC30 with a 100 % confidence, indicating the 
accuracy of the model.  
Mapping of the mutated residues on the model structure (Fig. 5a) indicated that the 
three putative catalytic residues, whose mutations led to complete loss of growth 
inhibition activity, are located in one place with nearly the same topologies and 
distances of the side chains with those of VapC30, possibly forming the catalytic center. 
The other residues whose mutations also resulted in complete or partial loss of activity, 
except for G94 and D124, are located around the putative catalytic center, suggesting 
that these residues are involved in substrate binding or structural maintenance of the 
putative catalytic center. In the case of G98, since the Gly residue acts as a helix breaker 
and this residue is located adjacent to one of the catalytic residues, D99, G98 may be 
required for correct positioning of D99; it remains unknown as to why the mutations of 
G94D and D124A lost growth inhibition activity. The E23, T72, L105, and V108 
residues are located at the other side of the protein. Therefore, it is possible that 
mutations of these residues did not affect activity.  
In order to examine the mutant proteins which lost growth inhibition activity 
biochemically, the proteins were purified using the same method as the wild type 
TtVapC. As shown in Fig. 5b, all of the mutant proteins were purified as single bands. 
Since this purification method relies on the complex formation with TtVapB, this result 
indicates that the mutations introduced did not affect binding to TtVapB. As expected, 
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all mutants lost RNase activities against total RNA (Fig. 5c), and one of the mutants, 
D99A, also lost activity against mRNA (Fig. 3c) and translation-inhibition activity (Fig. 
4).  
 
In conclusion, we characterized seven putative TA loci in T. thermophilus, and 
found that the three loci, TTC0125-TTC0126, TTC1395-TTC1396, and TTC1705-
TTC1706, function as a TA module, indicated by the E. coli growth-inhibition assay. 
Biochemical analysis indicated that TtVapC catalyzes degradation of RNA and inhibits 
translation by degrading free mRNA, and TtVapB inhibits its activity as the antitoxin. 
Nine catalytically-important residues in TtVapC, including the three putative catalytic 
residues, were identified, most of which are located near the catalytic center of the 
three-dimensional model. 
 Most vapBC loci in microorganisms consist of a bicystronic operon but the 
TtvapBC locus is included in a gene cluster encoding metabolic enzymes related to the 
glyoxylate cycle. It is possible that the physiological function of TtVapBC is related to 
this cycle. 
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Fig. 1 Growth inhibition assay  
E. coli DH5αZ1 harboring pZE21MCS2 containing toxin genes (a) of TTC0113 (1), 
TTC0125 (2), TTC1207 (3), TTC1804 (4), TTC1395 (5), TTC1549 (6), TTC1705 (7), 
or those with respective antitoxin genes (b) were cultured in LB medium containing 
kanamycin at 43 ºC; cell growth was monitored by measuring O.D.600. At O.D.600≈0.2, 
Dox was added to induce gene expression. Open circles with dotted lines indicate the 
culture without induction and filled circles with solid lines indicate the culture with 
induction. Panel (8) indicates the results from the strain harboring the vector plasmid. 
Culturing was conducted three times, and the mean values±standard deviations are 
shown. 
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Fig. 2 SDS-PAGE of the purified TtVapBC proteins  
Lane M, molecular marker (in kDa); 1, TtVapB; 2, TtVapC.
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Fig. 3 RNA degradation assay 
Total RNA from E. coli (a), T. thermophilus (b), and the in vitro-transcribed tetR mRNA 
(c) were incubated with the purified TtVapC for 5 (lane 1), 10 (lane 2), 30 (lane 3), or 60 
(lane 4) min, or incubated with the TtVapBC complex (lane 5) or TtVapC D99A mutant 
(lane 6) for 60 min and electrophoresed by denaturing agarose gel. Lanes C indicate the 
RNA samples without TtVapC treatment, which were also incubated in Reaction buffer 
for 60 min. Positions of 23S, 16S rRNA, and mRNA are indicated by arrows. 
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Fig. 4 In vitro translation inhibition assay 
The in vitro-transcribed TT_P0042 mRNA or the E. coli ribosome fraction in the 
PUREFrex 2.0 kit were incubated with the TtVapC or TtVapBC complex, as described 
in Materials and methods, and in vitro translation reactions were conducted by adding 
other components of the kit. The translated product was resolved by SDS-PAGE and 
detected by Western blotting with an anti-His antibody. Lane 1, the mRNA was pre-
incubated with TtVapC (Condition 1); 2, the mRNA was pre-incubated with TtVapC, 
and then TtVapB was added (Condition 2); 3, the mRNA was pre-incubated with 
TtVapBC complex (Condition 3); 4, the mRNA was pre-incubated with TtVapC D99A 
mutant in Condition 1; 5, the ribosome was pre-incubated with TtVapC (Condition 4); 6, 
the ribosome was pre-incubated with TtVapC, and then TtVapB was added (Condition 
5); 7, the ribosome was pre-incubated with TtVapBC complex (Condition 6); and 8, the 
ribosome was pre-incubated with TtVapC D99A mutant in Condition 4. Lanes NC and 
PC indicate negative control without the template mRNA addition and positive control 
without TtVapC treatment, respectively. Lane M indicates the molecular marker 
standards (MagicMark XP Western Protein Standard, Thermo Fisher Scientific), the size 
of which are indicated on the right. The bands corresponding to the full-length 
translated product is indicated by an arrow. 
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Fig. 5 Identification of catalytically-important residues of TtVapC   
(a) Three-dimensional model of TtVapC constructed by the Phyre2 program. Residues 
to which the mutations were introduced are shown with side chains and introduced 
mutations are indicated. Residues whose mutations affected growth inhibition activity 
are shown in orange and magenta, of which orange residues indicate the putative 
catalytic residues. Those whose mutations did not affect the activity are shown in blue. 
(b, c) Purification (b) and RNA-degrading assay (c) of the purified TtVapC mutants. 
Lane 1, wild type TtVapC; 2, D4A; 3, E40A; 4, A76D; 5, G94D; 6, G98D; 7, D99A; 8, 
S102D; 9, D119A; 10, D124A mutants. Lanes M and C indicate molecular markers (in 
kDa) and a control experiment without TtVapC incubation, respectively. RNA-
degradation assays were conducted with E. coli total RNA, and the positions of 23S and 
16S rRNA are indicated by arrows. 
 
